2 terminated. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Terminated 2 |
Follow Pimodivir 600 mg: new trials by email Literature Review of Pimodivir 600 mg trials Research Report on Pimodivir 600 mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Non-Hospitalized Participants With Influenza A Infection Who Are at Risk of Developing Complications Pimodivir 600 mg, Placebo, SOC Treatment - Influenza A | Phase 3 | Terminated | Janssen Research & Development, LLC | 553 | 2018-01-21 | 2025-02-04 |
| A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Hospitalized Participants With Influenza A Infection Pimodivir 600 mg, Placebo, SOC Treatment - Influenza A | Phase 3 | Terminated | Janssen Research & Development, LLC | 334 | 2018-01-03 | 2025-02-04 |
Janssen Research & Development, LLC (2)
Argentina (2) · Australia (2) · Austria (2) · Belgium (2) · Brazil (2) · Bulgaria (2) · Canada (2) · Chile (2) · China (2) · Czechia (2) · France (2) · Germany (2) · Hungary (2) · India (2) · Israel (2)
2017 (2)